首页> 外文OA文献 >Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States

【2h】

Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States

机译：目前监管毒理学对美国处方药产品发育的观点

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kuei-Meng Wu; Hanan Ghantous; Debra B. Birnkrant;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. [J] . Wu KM, Ghantous H, Birnkrant DB Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research . 2008,第8期

机译：在美国，目前有关从草药到处方药产品的开发的毒理学监管观点。
2. Regulatory toxicology perspectives on the development of botanical drug products in the United States. [J] . Wu KM, Farrelly J, Birnkrant D, American journal of therapeutics . 2004,第3期

机译：在美国，有关植物药产品开发的法规毒理学观点。
3. Concurrent use of herbal products with prescription drugs is a double-edged sword and evidence-based medicine contributes to reshaping the practice [J] . Leung Elaine Lai-Han, Wu Qi-Biao Pharmacological research: The official journal of The Italian Pharmacological Society . 2019,第期

机译：同时使用中草药具有处方药，是一种双刃剑，循证医学有助于重塑实践
4. Medical Plants in Usadha: Loloh as Balinese Medicine and Traditional Herbal Product in Educational Perspective [C] . I. W. Rasna, D. K. Tantra International Conference on Innovative Research Across Disciplines . 2017

机译：USADHA的医疗植物：LOLOH作为巴厘岛医学和教育视角的传统草药产品
5. Over-the-Counter Drugs and Prescription Drugs: Development of a Regulatory Database and Data Analysis of Warning Letters between Fiscal Years 2015–2019 [D] . Bai, Helen Kijung. 2020

机译：逆逆药物和处方药：2015-2019财政年度的警告信的监管数据库和数据分析的发展
6. Current Scientific and Regulatory Approaches for Development of Orally Inhaled and Nasal Drug Products: Overview of the IPAC-RS/University of Florida Orlando Inhalation Conference [O] . Guenther Hochhaus, Craig Davis-Cutting, Martin Oliver, 2015

机译：开发口服吸入和鼻用药物产品的当前科学和法规方法：IPAC-RS /佛罗里达大学奥兰多吸入会议的概述
7. Current regulatory perspectives on genotoxicity testing for botanical drug product development in the U.S.A. [O] . Kuei-Meng Wu, Jinhui Dou, Hanan Ghantous, 2010

机译：目前美国植物药物产品开发的基因毒性检测监管透视。
8. Total Medical and Prescription Expenditures by Current Assthma Status and Whether Asthma Daily Preventive Medicine is Being Taken, United States, 2006. Statistical Brief No. 241 [R] . Chevarley, F. M. 2009

机译：按现行哮喘状况划分的医疗和处方总支出以及是否采用哮喘日常预防医学，美国，2006年。统计摘要第241号

Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States

著录项

引文网络

相似文献

相关主题

期刊订阅